Palvella Therapeutics (PVLA) Cash from Investing Activities (2016 - 2024)
Historic Cash from Investing Activities for Palvella Therapeutics (PVLA) over the last 11 years, with Q3 2024 value amounting to $142000.0.
- Palvella Therapeutics' Cash from Investing Activities rose 10715.73% to $142000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $14.8 million, marking a year-over-year increase of 5286.75%. This contributed to the annual value of $12.0 million for FY2023, which is 15651.72% up from last year.
- Palvella Therapeutics' Cash from Investing Activities amounted to $142000.0 in Q3 2024, which was up 10715.73% from $2.2 million recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Cash from Investing Activities registered a high of $18.4 million during Q3 2020, and its lowest value of -$16.9 million during Q1 2022.
- Moreover, its 5-year median value for Cash from Investing Activities was $414000.0 (2020), whereas its average is $2.1 million.
- The largest annual percentage gain for Palvella Therapeutics' Cash from Investing Activities in the last 5 years was 166285.71% (2022), contrasted with its biggest fall of 6042857.14% (2022).
- Over the past 5 years, Palvella Therapeutics' Cash from Investing Activities (Quarter) stood at $14.9 million in 2020, then plummeted by 102.3% to -$342000.0 in 2021, then surged by 423.68% to $1.1 million in 2022, then soared by 211.56% to $3.4 million in 2023, then crashed by 95.88% to $142000.0 in 2024.
- Its Cash from Investing Activities stands at $142000.0 for Q3 2024, versus $2.2 million for Q2 2024 and $9.0 million for Q1 2024.